-
Teva introduces dexmethylphenidate hydrochloride capsules
NORTH WALES, Pa. — Teva Pharmaceuticals on Wednesday announced the introduction and availability of dexmethylphenidate hydrochloride extended-release capsules, CII, in 15-mg and 30-mg strengths. This product is AB rated and bioequivalent to Focalin XR extended-release capsules, CII.
With the addition of these two new strengths, Teva now offers dexmethylphenidate HCl extended-release capsules, CII in 15-mg, 30-mg and 40-mg.